Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
PT Kedoya Adyaraya Tbk operates as an Indonesian healthcare enterprise, managing and owning hospitals throughout the country. The company delivers a broad spectrum of medical services across numerous specialties, encompassing comprehensive surgical procedures such as general, orthopedic, urological, cardiothoracic, plastic, and neurological operations. It also provides internal medicine subspecialties like nephrology, endocrinology, and general internal medicine, alongside care in obstetrics and gynecology, cardiology, neurology, pulmonology, ophthalmology, hyperbaric medicine, and pediatrics. Additional services include acupuncture, medical rehabilitation, and speech therapy. Oral health is addressed through oral and maxillofacial services, prosthodontics, and general dentistry. Furthermore, mental health support is provided by psychiatrists and psychologists, nutritional guidance by dietitians, and specialized treatment for skin and venereal conditions. Beyond these specialized areas, the company also offers general medical care. As of December 31, 2021, PT Kedoya Adyaraya Tbk operated two hospitals, offering a combined capacity of 200 patient beds. Established in 1990, the company's main office is located in Jakarta Barat, Indonesia, and it functions as a subsidiary of PT Sarana Meditama Metropolitan Tbk.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV